Statistics for Santhera Pharmaceuticals Holding AG (id:13174 SANN)

Valuation metrics

Market cap

100.48M

Enterprise value

107.00M

Trailing P/E (ttm)

1.44

Forward P/E

-2.64

PEG ratio

-2.64

Price/Sales (ttm)

0.88

Price/Book (mrq)

2.02

Enterprise Value/Revenue

0.94

Enterprise Value/EBITDA

1.87

Overview

Shares outstanding

12.11M

Float

8.75M

Shares short

% Held by insiders

0.21%

% Held by institutions

0.03%

Average volume (10 days)

10.97K

Average volume (90 days)

Price summary

52-Week low

7.21

52-Week high

11.44

52-Week change

-15.82%

Beta

0.13

50-Day moving average

9.01

200-Day moving average

9.30

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

September 08th, 2022

Ex-dividend date

Last split factor

2:1

Last split date

July 03th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

55.34%

Operating margin

-125.70%

Operational effectiveness

Return on assets

39.20%

Return on equity

2.37K%

Income statement

Revenue (ttm)

10.65

Revenue per share (ttm)

10.65

Quarterly revenue growth (yoy)

Gross profit (ttm)

100.18M

EBITDA

53.46M

Net income to common (ttm)

62.86M

Diluted EPS (ttm)

5.75

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

16.49M

Total cash per share (mrq)

1.41

Total debt (mrq)

26.37M

Total Debt/Equity (mrq)

54.88

Current ratio (mrq)

63.40%

Book value per share (mrq)

4.11

Cash flow

Cash flow statement

47.35M

Levered free cash flow (LFCF)

-24,751,876.00